Xi Su

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Papillary Thyroid

Breast Cancer Cells

Top Venues

Journal of experimental & clinical cancer research : CR

Cell death and differentiation

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Xi Su, Dong Chen, Lizhang Zhu, Hao Jia, Jiaxuan Cai, Peng Li, Bin Han, Donglai Wang, Hongtao Li, Jiaqian Fan, Mengwei Gu, Yaqi Zhou, Haixia Guan, Wei Wei
SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition. Cell death & disease 13 (3) (2022)
Xi Su, Peng Li, Bin Han, Hao Jia, Qingzhuang Liang, Haichao Wang, Mengwei Gu, Jiaxuan Cai, Shaolei Li, Yaqi Zhou, Xin Yi, Wei Wei
Vitamin C sensitizes BRAFV600E thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK/ERK signal by PLX4032. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Xi Su, Chao Feng, Simeng Wang, Liang Shi, Qingqing Gu, Haihong Zhang, Xinhui Lan, Yuelei Zhao, Wei Qiang, Meiju Ji, Peng Hou
The noncoding RNAs SNORD50A and SNORD50B-mediated TRIM21-GMPS interaction promotes the growth of p53 wild-type breast cancers by degrading p53. Cell death and differentiation 28 (8) (2021)